{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:30:54Z","timestamp":1790094654461,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3841,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1111\/j.1523-1755.2005.00338.x","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T14:20:14Z","timestamp":1115389214000},"page":"2330-2337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD"],"prefix":"10.1016","volume":"67","author":[{"given":"Francesca","family":"Mallamaci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Cutrupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo S.","family":"Malatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Zoccali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0010","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am J Med"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0030","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2002.00637.x","article-title":"Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?","volume":"62","author":"Stenvinkel","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0035","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1046\/j.1523-1755.2001.0590041559.x","article-title":"Diagnostic potential of cardiac natriuretic peptides in dialysis patients","volume":"59","author":"Mallamaci","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000065272","article-title":"The prognostic role of brain natriuretic peptides in hemodialysis patients","volume":"22","author":"Naganuma","year":"2002","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0045","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","article-title":"Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease","volume":"10","author":"Kielstein","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0050","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0055","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.V1271508","article-title":"Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients","volume":"12","author":"Zoccali","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.290.3.353","article-title":"Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis","volume":"290","author":"DeFilippi","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1681\/ASN.V75728","article-title":"Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease","volume":"7","author":"Foley","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0070","series-title":"Kidney Int","first-page":"S2","article-title":"Mathematic modelling of dialysis therapy","author":"Sargent","year":"1980"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0272-6386(95)90494-8","article-title":"Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and haemodialysis patients","volume":"26","author":"Cianciaruso","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00004872-200018090-00006","article-title":"Inflammation is associated with carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients","volume":"18","author":"Zoccali","year":"2000","journal-title":"J Hypertens"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0085","series-title":"Modelling Survival Data in Medical Research","first-page":"72","author":"Collet","year":"1994"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0090","series-title":"Applied Survival Analysis","first-page":"196","article-title":"Assessment of model adequacy","author":"Hosmer","year":"1999"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0095","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1046\/j.1523-1755.2003.00860.x","article-title":"Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 study","volume":"63","author":"Foley","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/ajkd.2002.34509","article-title":"Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients","volume":"40","author":"Fung","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.290.7.891","article-title":"Major risk factors as antecedents of fatal and nonfatal coronary heart disease events","volume":"290","author":"Greenland","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5414\/CNP57327","article-title":"Cardiovascular disease risk factors in chronic renal insufficiency","volume":"57","author":"Sarnak","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(97)03034-1","article-title":"Biochemical detection of left-ventricular systolic dysfunction","volume":"351","author":"McDonagh","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0125","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetrical dimethylarginine: The Uber marker?","volume":"109","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0130","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1681\/ASN.V132490","article-title":"Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease","volume":"13","author":"Zoccali","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0135","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00004872-200018090-00006","article-title":"Inflammation is associated with carotid atherosclerosis in dialysis patients","volume":"18","author":"Zoccali","year":"2000","journal-title":"J Hypertens"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1523-1755.2002.00437.x","article-title":"Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients","volume":"62","author":"Zoccali","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0145","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/ajkd.2002.36891","article-title":"Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in hemodialysis patients","volume":"40","author":"Park","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0150","series-title":"Kidney Int","first-page":"S222","article-title":"Rationale and design of a trial improving outcome of type 2 diabetics on hemodialysis. Die Deutsche Diabetes Dialyse Studie Investigators","author":"Wanner","year":"1999"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0155","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0735-1097(99)00250-8","article-title":"Cause of death in clinical research: Time for a reassessment?","volume":"34","author":"Lauer","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1523-1755.2005.00338.x_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/ajkd.2002.29905","article-title":"Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration","volume":"39","author":"Rocco","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815507229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815507229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:45:55Z","timestamp":1758761155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815507229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0085253815507229"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00338.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00338.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}